HK1025558A1 - Optically active 2-aminotetraline, process for its preparation and pharmaceutical compositions containing same, active in preventing and treating septic shock - Google Patents

Optically active 2-aminotetraline, process for its preparation and pharmaceutical compositions containing same, active in preventing and treating septic shock

Info

Publication number
HK1025558A1
HK1025558A1 HK00102411A HK00102411A HK1025558A1 HK 1025558 A1 HK1025558 A1 HK 1025558A1 HK 00102411 A HK00102411 A HK 00102411A HK 00102411 A HK00102411 A HK 00102411A HK 1025558 A1 HK1025558 A1 HK 1025558A1
Authority
HK
Hong Kong
Prior art keywords
active
preventing
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
HK00102411A
Other languages
English (en)
Inventor
Gian Piero Moretti
Piero Foresta
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of HK1025558A1 publication Critical patent/HK1025558A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HK00102411A 1997-02-03 2000-04-20 Optically active 2-aminotetraline, process for its preparation and pharmaceutical compositions containing same, active in preventing and treating septic shock HK1025558A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97RM000050A IT1290910B1 (it) 1997-02-03 1997-02-03 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive
PCT/IT1998/000011 WO1998033762A1 (en) 1997-02-03 1998-01-28 Optically active 2-aminotetraline, process for its preparation and pharmaceutical compositions containing same, active in preventing and treating septic shock

Publications (1)

Publication Number Publication Date
HK1025558A1 true HK1025558A1 (en) 2000-11-17

Family

ID=11404706

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00102411A HK1025558A1 (en) 1997-02-03 2000-04-20 Optically active 2-aminotetraline, process for its preparation and pharmaceutical compositions containing same, active in preventing and treating septic shock

Country Status (11)

Country Link
US (1) US6225501B1 (de)
EP (1) EP0968174B1 (de)
JP (1) JP2001509802A (de)
AT (1) ATE231486T1 (de)
DE (1) DE69810906T2 (de)
DK (1) DK0968174T3 (de)
ES (1) ES2190581T3 (de)
HK (1) HK1025558A1 (de)
IT (1) IT1290910B1 (de)
PT (1) PT968174E (de)
WO (1) WO1998033762A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1294931B1 (it) * 1997-09-22 1999-04-23 Sigma Tau Ind Farmaceuti Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella
IT1317050B1 (it) * 2000-06-23 2003-05-26 Sigma Tau Ind Farmaceuti Tetraline 2,6,7-sostituite utili per la preparazione di un medicamentoad attivita' inibitrice della fosfodiesterasi iv.
CN103360360A (zh) * 2012-04-10 2013-10-23 肖竹平 一种基于二氢杨梅素制备(+)-没食子儿茶素的方法
US11192856B2 (en) 2017-10-05 2021-12-07 Biogen Inc. Process for preparing alpha-carboxamide pyrrolidine derivatives
CN114222728A (zh) * 2019-04-10 2022-03-22 生物基因公司 制备α-甲酰胺吡咯烷衍生物的方法
CN115724758A (zh) * 2021-08-24 2023-03-03 杭州中美华东制药有限公司 喜树碱衍生物中间体及其合成方法和利用中间体合成喜树碱衍生物的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241988B (it) * 1990-06-15 1994-02-02 Sigma Tau Ind Farmaceuti 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono
IT1278045B1 (it) * 1995-03-09 1997-11-17 Sigma Tau Ind Farmaceuti Uso di 2-amminotetraline-6,7-sostituite per la preparazione di composizioni farmaceutiche atte al trattamento dello shock, e di

Also Published As

Publication number Publication date
ATE231486T1 (de) 2003-02-15
ES2190581T3 (es) 2003-08-01
IT1290910B1 (it) 1998-12-14
WO1998033762A1 (en) 1998-08-06
PT968174E (pt) 2003-06-30
EP0968174A1 (de) 2000-01-05
DE69810906T2 (de) 2003-11-13
EP0968174B1 (de) 2003-01-22
ITRM970050A1 (it) 1998-08-03
DE69810906D1 (de) 2003-02-27
US6225501B1 (en) 2001-05-01
DK0968174T3 (da) 2003-05-12
JP2001509802A (ja) 2001-07-24

Similar Documents

Publication Publication Date Title
BG101139A (en) Heteroatoms-containing cyclopentanopyridyloxazolidinons
HK1010484A1 (en) Pharmaceutical composition for use in treatment ofdiabetes.
HU9603495D0 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, as pharmaceutical agents
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
BG101131A (en) 2-oxo-and 2-thio-1,2-dihydroquinolinyl-oxazolidinons
PL340890A1 (en) Adamantane derivatives
PL340906A1 (en) Adamantane derivatives
DE69835201D1 (en) Neoglycoproteine
NZ333588A (en) Sulphamates as anticonvulsant derivatives useful in treating amyotrophic lateral sclerosis (ALS)
HK1017995A1 (en) Compounds and compositions for delivering active agents.
ZA973647B (en) Inhibitors of metalloprotease, process for preparing them and pharmaceutical compositions containing them.
SE9704546D0 (sv) Novel compounds
ZA972147B (en) Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical active ingredients.
HUP9802408A3 (en) Naphthyl and dihydronaphthyl-derivatives, and pharmaceutical compositions, containing them
HK1040980A1 (zh) 聯苯磺酰基氨基氰、其製備方法及其作為藥物的用途
ZA934037B (en) Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same.
ZA968081B (en) Pharmaceutical composition.
ZA9610460B (en) New phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions.
EP0683668A4 (de) Präparate und verfahren für eine transdermale arzneistoffverabreichung.
IL135316A0 (en) Oxyranyle-triazoline thiones and their use as microbicides
HUP0001093A3 (en) Oxazolidines as 5-ht2a-antagonists, pharmaceutical compositions containing the same and process for their preparation
HK1010885A1 (en) 10,13,15-trioxatricyclo [9.2.1.1.9.6]-pentadecanone-derivatives, process for their preparation and pharmaceutical containing them
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
CY2482B1 (en) Paroxetine in treatment of depression.
EP0622369A3 (de) 2-Amino-4-chinolin-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung.

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20080128